Escalon Medical Corp (ESMC) stock

Escalon Medical Corp grew revenue 5.7% to $12.74M over the twelve months to Jun 30, 2026. Operating income fell 66.0% to $45.24K, moving the operating margin from 1.1% to 0.4%. Free cash flow was -$407.03K, down 208.0% from a year earlier. At the latest close the market valued the company at $2.72M, 0.7 times its earnings.

Escalon Medical Corp. develops, manufactures, markets, and distributes medical devices primarily for ophthalmic healthcare applications. The company's ophthalmic product portfolio features diagnostic ultrasound systems, including A-Scans for internal eye measurement, B-Scans for two-dimensional imaging of opaque ocular structures, high-resolution ultrasound biomicroscopy devices for anterior segment evaluation, and pachymeters for measuring corneal thickness. In addition to diagnostic equipment, it provides intraocular gases with delivery kits and disposable surgical packs for vitreoretinal procedures. The business also offers an image management platform that allows medical professionals to view and organize diagnostic images across multiple devices and locations. Escalon primarily markets and sells its products directly to medical institutions, vitreoretinal surgeons, and healthcare facilities worldwide.